@cslbehring.com
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
CSL, also known as CSL Limited, is a global biotechnology company headquartered in Parkville, Victoria, Australia. However, it has a significant presence in the United States with its extensive operations and regional headquarters located in King of Prussia, Pennsylvania. Founded in 1916 as the Commonwealth Serum Laboratories in Melbourne, Australia, CSL has a rich history dating back over a century.
Initially established to address vaccine shortages during World War I, CSL played a crucial role in providing life-saving products to the Australian population. Over the years, the company expanded its product portfolio and began producing a range of pharmaceuticals, including blood plasma products and vaccines. Today, CSL focuses on life-saving innovations in the biotherapeutic sector.
Its main products and services revolve around plasma-derived therapies, recombinant proteins, influenza vaccines, and various other pharmaceutical treatments. The company's product lineup includes immunoglobulins, coagulation factors, albumin, and respiratory medicines. On a global scale, CSL operates through a network of subsidiaries and partnerships.
CSL Behring, a major subsidiary, specializes in developing and manufacturing plasma protein biotherapies for patients with rare diseases. It has a presence in more than 35 countries worldwide. CSL's joint venture with the China National Biotec Group, named CSL-Behring, develops plasma-based therapies for the Chinese market.
The company also collaborates with leading healthcare organizations and research institutions to advance medical advancements. CSL holds a strong market position in the biopharmaceutical industry. It has consistently achieved robust sales growth, with a significant portion of its revenue generated from the United States.
The company faces competition from other major pharmaceutical companies like Johnson & Johnson, Novartis, and Pfizer. In recent years, CSL has made notable achievements and changes to drive its growth. It has expanded its manufacturing capabilities, invested in research and development, and acquired companies to strengthen its product pipeline.
In 2020, CSL played a pivotal role in the development and production of a potential COVID-19 vaccine, demonstrating its dedication to global health crises. As of its latest updates, CSL continues to prioritize research and development to improve treatments for patients with rare diseases and focus on global pandemic responses. With its commitment to innovation and patient care, CSL remains at the forefront of the biotechnology industry.
Overall, CSL is a global biotechnology leader with a rich history, a diverse portfolio of life-saving products, and a strong market position. Its headquarters in the United States, along with its global operations and strategic partnerships, contribute to its ongoing success in the industry
Company Type
Public Company
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online